THE EVOLVING LANDSCAPE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: FROM PATHOGENESIS TO PRECISION MEDICINE
Non-Alcoholic Fatty Liver Disease (NAFLD), recently reclassified as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), represents one of the most significant challenges in modern hepatology and metabolic medicine (Rinella et al., 2023). This paper examines the evolution of the disease's nomenclature and...